End Stage Renal Disease
Study reveals 15% lower odds of arteriovenous access use at hemodialysis initiation among women vs men.
FGF-23 may have an effect on adipose tissue that contributes to an obesity paradox observed in patients with end-stage renal disease.
Type 2 diabetes is among the leading causes of end-stage renal disease (ESRD), but the estimated cumulative risk of ESRD at 20 years after diagnosis of type 2 diabetes is less than 1%.
Mean 25-hydroxyvitamin D levels did not differ significantly among groups receiving phosphate binders or dietary therapy.
Prospective study reveals that patients on hemodialysis whose blood selenium concentrations are in the lowest decile have a 3.4-fold higher odds of death.
Patients with end-stage renal disease (ESRD) due to autosomal polycystic kidney disease are more likely to receive a kidney transplant than those with ESRD from other causes, new study finds.
In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.
Fresenius Medical Care North America has promoted Ahmad Sharif, MD, MPH, to Chief Medical Information Officer for North America.
In an Israeli study, individuals who had any type of kidney disease as children had a 4-fold increased risk of end-stage renal disease in adulthood.
New study finds an increase in medical events and institutionalization in the months leading up to dialysis withdrawal.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)